Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Emerging Market Could Be the Next Big Thing in Biotech

TheMotleyFool

0 0

This Emerging Market Could Be the Next Big Thing in Biotech: https://g.foolcdn.com/editorial/images/739300/female-scientist-observing-with-microscope.jpg

In biotech, every threat to human health is a potentially lucrative opportunity to develop an effective treatment. As such, long COVID -- the poorly defined constellation of persistent symptoms that follows some people's acute bouts with the virus -- could soon become one of the pharmaceutical industry's most popular targets. Several companies are already in search of effective treatments for the condition, and more are likely to join the pursuit.

But why is long COVID such an appealing target for biotech? Which competitors are leading in the space right now, and which, if any, might be good investments for you?

Image source: Getty Images.

Source Fool.com

Like: 0

ARGX

Share